Table 2 Physical and 2DE structural and functional parameters at baseline
Level | Parameter | Group | ||
|---|---|---|---|---|
Control | Empagliflozin | |||
Body weight [gr] | 413 ± 35 | 395 ± 37 | ||
Apical level | Systolic | LVESA [mm2] | 16.4 ± 5.9 | 15.8 ± 5.3 |
LVIDs [mm] | 4.2 ± 0.7 | 4.6 ± 0.7 | ||
Diastolic | LVEDA [mm2] | 43.3 ± 4.9 | 39.2 ± 5.4 | |
LVIDd [mm] | 7.6 ± 0.6 | 7.0 ± 0.6 | ||
Function | FS [%] | 39.7 ± 3.9 | 35.6 ± 3.8 | |
FAC [%] | 63.1 ± 3.7 | 59.0 ± 3.7 | ||
EF [%] | 74.5 ± 6.4 | 70.4 ± 6.2 | ||
Papillary muscles level | Systolic | LVESA [mm2] | 20.5 ± 4.3 | 26.2 ± 4.3 |
LVIDs [mm] | 4.3 ± 0.6 | 4.9 ± 0.7 | ||
Diastolic | LVEDA [mm2] | 51.2 ± 4.7 | 47.1 ± 4.6 | |
LVIDd [mm] | 7.5 ± 0.6 | 7.3 ± 0.5 | ||
Function | FS [%] | 36.2 ± 3.1 | 39.7 ± 3.2 | |
FAC [%] | 52.3 ± 3.6 | 56.2 ± 4.0 | ||
EF [%] | 69.9 ± 5.3 | 76.4 ± 5.4 | ||